INTEGRATED BIOPHARMA INC - 8-K Filing

Integrated Biopharma reports Q2 and fiscal year revenue decline with operating losses (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $INBP

Read the full article at SEC EDGAR

More Regulatory news